Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute (Q45728593)

From Wikidata
Jump to navigation Jump to search
scientific article published in October 2012
edit
Language Label Description Also known as
English
Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute
scientific article published in October 2012

    Statements

    Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute (English)
    Mark S Rubin
    David R Spigel
    Ralph V Boccia
    Samuel Raby
    Raven Quinn
    F Anthony Greco
    1 October 2012
    217-223

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit